BASF SE (BASFY) Stock Price & Analysis
BASF SE (BASFY) is trading at USD 14.63, down 0.88% today, as of October 23, 2026 at 15:02 UTC (US market open; quotes may be delayed), according to Nexqual market data.
BASFY last closed at USD 14.76; today's session has ranged USD 14.58–14.63 on volume of 835 shares. Market capitalization is $50.38B, with a 52-week range of USD 11.93–16.25 (OQX). Source: Nexqual, retrieved October 23, 2026 at 16:40 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BASFY.md
Key facts (BASFY)
- Analysts: Sell (mean 4.00 on a 1–5 scale) (4 analysts), mean target USD 13.59 (range 12–16).
- Total return with dividends: 1Y +20.5% vs S&P 500 +14.6%; 5Y +9.9% vs S&P 500 +77.3%.
- Next earnings: 2026-10-28, EPS estimate USD —, revenue estimate $15.4B.
Analysts (BASFY)
Consensus Sell (mean 4.00 on a 1–5 scale), 4 analysts; mean target USD 13.59 (low 12, high 16).
Total return (dividends reinvested) (BASFY)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +20.5% | +9.9% |
| S&P 500 (SPY) | +14.6% | +77.3% |
| Per year | +20.5% | +1.9% |
| Volatility (annualized) | 25.6% | 30.9% |
| Max drawdown | -16.2% (May 2026→Jul 2026) | -46.9% (Jan 2022→Sep 2022) |
BASFY analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | — | — | — | $15.35B | — |
| Next quarter (ends Dec 2026) | — | — | — | $14.28B | — |
| Current fiscal year (ends Dec 2026) | $0.75 | $0.76 | -1.9% | $63.44B | 1 |
| Next fiscal year (ends Dec 2027) | $0.66 | $0.77 | -14.6% | $64.40B | 1 |
Key Statistics (as of October 23, 2026 at 16:40 UTC)
| Price | USD 14.63 |
|---|---|
| Change | ▼ 0.88% (down) |
| Previous Close | USD 14.76 |
| Open | USD 14.58 |
| Day Range | USD 14.58 – 14.63 |
| 52-Week Range | USD 11.93 – 16.25 |
| Volume | 835 shares |
| Market Cap | $50.38B |
| Exchange | OQX |
Technical Analysis (BASFY)
Nexqual's technical model rates BASFY "NEUTRAL" based on 2 bullish and 3 bearish signals across 128 daily candles, as of October 23, 2026 at 16:40 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 44.57 (neutral) |
| vs SMA50 | Below (USD 14.86) |
| MACD | 0.01 (positive) |
Analyst Ratings (BASFY)
Wall Street analysts rate BASFY "Sell" based on 4 analysts, with a mean price target of USD 13.59 (range USD 12–16), per Nexqual as of October 23, 2026 at 16:40 UTC.
| Consensus Rating | Sell |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 13.59 |
| High Target | USD 16 |
| Low Target | USD 12 |
| Buy / Hold / Sell | 0 / 2 / 2 |
Earnings (BASFY)
| Next Earnings Date | 2026-10-28 |
|---|---|
| Revenue Estimate | $15.35B |
Source: Nexqual, October 23, 2026 at 16:40 UTC.
Financials & Fundamentals (BASFY)
| Total Revenue | $61.59B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +16.40% |
| Gross Margin | +23.55% |
| Operating Margin | +5.18% |
| Profit Margin | +9.42% |
| ROE | +6.12% |
| Debt / Equity | 0.71 |
| Current Ratio | 1.86 |
| Total Cash | $7.89B |
| Total Debt | $26.68B |
Source: Nexqual, October 23, 2026 at 16:40 UTC.
Financial Health Score (BASFY)
Nexqual rates BASF SE's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 16:40 UTC.
| Growth | Weak — Revenue -9% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 24%, operating 5% (last 12 months) |
| Balance Sheet | Solid — EUR 7.89B cash vs EUR 26.7B debt |
| Cash Flow | Solid — Operating cash flow EUR 4.73B (TTM) |
| Efficiency | Mixed — ROE 6%, ROA 2.3% |
Ownership (BASFY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.10% |
| Shares Outstanding | 3.44B |
| Float | 3.46B |
Source: Nexqual, October 23, 2026 at 16:40 UTC.
Leadership (BASFY)
BASF SE is led by Markus Kamieth, CEO & Chairman of the Board of Executive Directors, per Nexqual as of October 23, 2026 at 16:40 UTC.
| CEO & Chairman of the Board of Executive Directors | Markus Kamieth |
|---|---|
| Member of the Board of Executive Directors, CFO & Chief Digital Officer | Dirk Elvermann |
| Member of the Board of Executive Director & President of the Nutrition and Health Division | Anup Kothari |
| CTO & Member of the Board of Executive Directors | Stephan Kothrade |
| Member of the Board of Executive Director | Katja Scharpwinkel |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DOW | Dow Inc. | USD 32.68 | ▲ 2.72% |
| CE | Celanese Corporation | USD 47.06 | ▼ 0.35% |
| MEOH | Methanex Corporation | USD 63.5 | ▲ 4.54% |
| OLN | Olin Corporation | USD 15.74 | ▲ 1.25% |
| HUN | Huntsman Corporation | USD 8.87 | ▲ 1.72% |
| REX | REX American Resources Corporat | USD 39.8 | ▼ 0.06% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 16:40 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt